| answer text |
<p>The Department was made aware of a global supply issue with Creon 25000 gastro-resistant
capsules in autumn 2023. We worked with the manufacturers to resolve that issue and
stock is currently available. We are continuing to work with the manufacturers of
Creon 25000 to help ensure that action is taken to resolve any further issues that
may arise, as quickly as possible, to maintain continuity of supply of this important
medicine for patients in the United Kingdom.</p><p>We understand how frustrating and
distressing medicine supply issues can be. While we can’t always prevent supply issues
from occurring, the Department has a range of well-established processes and tools
to manage them when they arise and help mitigate risks to patients.</p>
|
 |
